Delivery Order SPE2DB24D2205-SPE2DB25FEHGS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,334.12 on August 13, 2025, for Flarex 0.1% eye drops (5mL). This competitive award, which is not set-aside and features firm fixed-price pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Flarex 0.1% eye drops in a 5ML formulation, valued at $6,379.24. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger pharmaceutical supply agreement. The order is expected to be completed by August 21, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,587.60 to AmerisourceBergen Drug Corp for FLAREX 0.1% eye drops (5 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $4,510.23 to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on July 23, 2025, with completion expected by July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FLAREX 0.1% eye drops. The award has a ceiling value of $7,019.88 and is a firm fixed-price contract with an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing this critical medical product to support the healthcare needs of military treatment facilities and other federal healthcare providers. This...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLAREX 0.1% eye drops in 5 milliliter units, with a ceiling value of $7,127.40 and a final completion date of July 14, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of FLAREX 0.1% eye drops. The $2,533.92 contract has an ultimate completion date of August 21, 2024. The order is not set aside for any small business designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
- This is a $26,989.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLAREX 0.1% EYE DROPS 5ML, a medical product used to treat various eye conditions. The contract has an ultimate completion date of March 8, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with...
- This is a delivery order for $10,832.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide FLAREX 0.1% eye drops. The contract has a firm fixed price and a completion date of September 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities, including...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FLAREX 0.1% eye drops. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,878.33 and an ultimate completion date of June 18, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHGSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,927.39 to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on September 9, 2025, with an ultimate completion date of September 10, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of delivery orders through the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for ophthalmic medication represents a routine fulfillment under the company's broader prime vendor agreement, enabling flexible pharmaceutical support to Defense Health Agency customers and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 9/9/25 |